Director Global Regulatory Strategy
Bayer
Colleen Witt, Director Global Regulatory Strategy at Bayer, where she is responsible for the development and execution of global regulatory strategies for medical devices, including but not limited to standalone software applications, artificial intelligence/machine learning (AI/ML) technologies, and CT/MR injectors. Colleen is an experienced professional in the medical device industry, holding roles in both clinical research and regulatory affairs for approximately 25 years. She obtained her Master’s in Regulatory Affairs from the University of Southern California and holds a Regulatory Affairs Certification (RAC).
Sponsored Presentation: Implementing flexibility and efficiency in labeling change management
Thursday, October 9, 2025
11:55 AM - 12:20 PM EST